Company Filing History:
Years Active: 1998-1999
Title: The Innovations of Carlos Estenio Hormaeche
Introduction
Carlos Estenio Hormaeche is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of immunology, particularly in the development of vaccines. With a total of 4 patents to his name, Hormaeche's work has had a profound impact on vaccine technology.
Latest Patents
Hormaeche's latest patents include groundbreaking innovations in vaccine development. One of his patents focuses on vaccines containing bacteria that are attenuated by mutation of the htrA gene. This attenuated microorganism is designed for use in immunoprophylaxis, where the attenuation is achieved through a mutation in the DNA sequence that encodes a protein responsive to environmental stress. Additionally, he has developed vaccines containing bacteria that are attenuated by mutations in two genes of the organism's aromatic pathway. These organisms can be genetically engineered to express antigens from other pathogens, forming the basis for a range of multi-valent vaccines.
Career Highlights
Hormaeche has had a distinguished career, working with Glaxo Wellcome Inc., a leading pharmaceutical company. His research and innovations have contributed to advancements in vaccine technology, making a significant difference in public health.
Collaborations
Hormaeche has collaborated with esteemed colleagues such as Steven Neville Chatfield and Gordon Dougan. These collaborations have further enhanced the impact of his research and innovations in the field of immunology.
Conclusion
Carlos Estenio Hormaeche is a prominent figure in the field of vaccine development, with a focus on innovative approaches to immunoprophylaxis. His contributions continue to shape the future of immunology and public health.